About 200 reports

  • China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2016
  • China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2016

Further, Oncology Test has been categorized into three main types: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing.

  • HPV Testing
  • Molecular Diagnostics
  • China
  • East Asia
  • OriGene Technologies, Inc.

OTHER COLORECTAL CANCER SCREENING TESTS COVERED IN THIS MODEL ARE BLOOD BASED ASSAYS THAT ARE USED TO SCREEN FOR COLORECTAL CANCER BY IDENTIFYING CHANGES IN THE METHYLATION STATUS OF THE SEPTIN ## GENE.

  • Molecular Diagnostics
  • Brazil
  • South America
  • Market Size
  • Abbott Laboratories, Inc.

OTHER COLORECTAL CANCER SCREENING TESTS COVERED IN THIS MODEL ARE BLOOD BASED ASSAYS THAT ARE USED TO SCREEN FOR COLORECTAL CANCER BY IDENTIFYING CHANGES IN THE METHYLATION STATUS OF THE SEPTIN ## GENE.

  • Molecular Diagnostics
  • Latin America
  • Mexico
  • North America
  • Market Size
  • ONCOLOGY MARKET, ITALY, AVERAGE PRICE ($), 2021-2025
  • ONCOLOGY MARKET, ITALY, AVERAGE PRICE ($), 2015-2020

OTHER COLORECTAL CANCER SCREENING TESTS COVERED IN THIS MODEL ARE BLOOD BASED ASSAYS THAT ARE USED TO SCREEN FOR COLORECTAL CANCER BY IDENTIFYING CHANGES IN THE METHYLATION STATUS OF THE SEPTIN ## GENE.

  • Molecular Diagnostics
  • Italy
  • Southern Europe
  • Market Size
  • Abbott Laboratories, Inc.

OTHER COLORECTAL CANCER SCREENING TESTS COVERED IN THIS MODEL ARE BLOOD BASED ASSAYS THAT ARE USED TO SCREEN FOR COLORECTAL CANCER BY IDENTIFYING CHANGES IN THE METHYLATION STATUS OF THE SEPTIN ## GENE.

  • Molecular Diagnostics
  • East Asia
  • South Korea
  • Market Size
  • Abbott Laboratories, Inc.

OTHER COLORECTAL CANCER SCREENING TESTS COVERED IN THIS MODEL ARE BLOOD BASED ASSAYS THAT ARE USED TO SCREEN FOR COLORECTAL CANCER BY IDENTIFYING CHANGES IN THE METHYLATION STATUS OF THE SEPTIN ## GENE.

  • Molecular Diagnostics
  • Eastern Europe
  • Russia
  • Market Size
  • Abbott Laboratories, Inc.
  • COMPANION DIAGNOSTICS MARKET
  • COMPANION DIAGNOSTICS MARKET

Breast cancer, prostate cancer, lung and bronchus cancer, and colorectal cancer were the most common types of cancers in Mexico.

  • Molecular Diagnostics
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • 12.6.6 Key Developments

Table ##.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Cancer Genetics, Inc.

Based on type of cancer, the oncology market is segmented into lung, breast, colorectal, prostate, ovarian, melanoma, ovarian and other cancers.

  • Diagnostics
  • Molecular Diagnostics
  • World
  • Market Shares
  • Market Size

Molecular Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Molecular Diagnostics
  • APAC
  • World
  • Market Size

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By Technology, By Application, By Region And Segment Forecasts, 2020 - 2027 Chapter ## Methodology and Scope ##. ## Market Segmentation ##. ## Research Methodology ##. ## Research Assumptions ##. ##. ## Est

  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Forecast

Colorectal cancer ##. ##. ##.

  • Diagnostics
  • Molecular Diagnostics
  • APAC
  • Company Financials
  • Market Size

The collaboration has ensured Day-One patient access to FDA-approved molecular tests paired with newly approved drugs for cancer.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.

Oncology ##. ##. ##. ## Oncology market, 2014 - 2026 (USD Million) ##. ##. ##. ## Breast cancer ##. ##. ##. ##. ## Breast cancer market, 2014 - 2026 (USD Million) ##. ##. ##. ## Prostate cancer ##. ##. ##. ##. ## Prostate cancer market, 2014 - 2026 (USD Million) ##. ##. ##. ## Colorectal

  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Forecast

The most common types of cancers in India include breast, cervical, oral cavity, lung, and colorectal cancer.

  • Molecular Diagnostics
  • North America
  • United States
  • World
  • Market Size
  • 5.5.3 Phase III Clinical Trails
  • 5.5.2 Phase II Clinical Trails

US The Netherlands Cancer Institute The Drug Rediscovery Protocol (DRUP Trial) (DRUP) The aim was to describe the efficacy and toxicity of commercially available, targeted anticancer drugs on advanced cancer patients and to perform next generation sequencing on tumor biopsies US En

  • Molecular Diagnostics
  • Europe
  • World
  • Forecast
  • Market Size
  • GLOBAL OTHER PCR-BASED MOLECULAR ASSAYS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET ANALYSIS- BY TECHNOLOGY

The cancer such as cervical and colorectal cancer are the commonly found cancers in the country.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

Cancer Incidence and Prevalence by Type ##-## ##. ## Breast cancer ##-## ##. ## Prostate cancer ##-## ##. ## Lung cancer ##-## ##. ## Colorectal cancer ##-## ##. ## Melanoma ##-## ##. ## Pancreatic cancer ##-## ##. ## Hepatocellular cancer ##-## ##. ## Cer

  • Diagnostics
  • Molecular Diagnostics
  • World
  • Forecast

LabCorp launched Epi proColon, a blood-based test for colorectal cancer screening that was approved on April ##, 2016 for clinical use by the U. S.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Agendia, Inc.
  • SAUDI ARABIA dPCR AND qPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

Studies on DNA polymorphism, lung cancer and colorectal cancer used dPCR and qPCR techniques In order to assess mRNA expression of genes.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Roche Group

Disease – China Molecular Diagnostic Test Volume ##. ## Oncology Test Volume ##. ##. ## Breast Cancer Test Volume ##. ##. ## Colorectal Cancer Test Volume ##. ##. ## Prostate Cancer Test Volume ##. ## Infectious Disease Test Volume ##. ##. ## Virology Test Volume ##. ##. ## HPV Test Volume ##. ##

  • Diagnostics
  • Molecular Diagnostics
  • Pathology
  • China
  • Market Shares

LIST OF FIGURES: LIST OF TABLES: ##.

  • Molecular Diagnostics
  • North America
  • United States
  • bioMerieux S.A.
  • Danaher Corporation

Cancer is one of the leading causes of death in Japan.

  • Molecular Diagnostics
  • North America
  • United States
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • 6.2.2 Colorectal Cancer Test Market
  • United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2010 - 2016

Oncology Test a) Breast Cancer ##) Molecular Diagnostics Market and Forecast ##) Segments Market & Forecast ##) Segments Test Volume & Forecast ##) Company Molecular Diagnostics Sales & Forecast b) Colorectal Cancer c) Prostate Cancer d) Others ##.

  • Molecular Diagnostics
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

REST OF WORLD PART D: ANNEXURE ##.

  • Molecular Diagnostics
  • APAC
  • United States
  • World
  • Market Shares
  • GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGIES IN $MILLON (2016-2026)
  • Global Molecular Diagnostics Market Size by technologies in $million (2016-2026)

Oncological diseases such as breast cancer, prostate cancer, colorectal cancer, lung cancer etc., respiratory diseases such as cystic fibrosis etc.

  • Molecular Diagnostics
  • Becton Property Group
  • bioMerieux S.A.
  • QIAGEN N.V.
  • Roche Group
  • MARKETED COMPANION DIAGNOSTIC TESTS, US, 2018 (3/5)

COLORECTAL CANCER: COMPETITIVE LANDSCAPE TO 2026, APRIL 2018, GDHC##CL GLOBALDATA (2017).

  • Molecular Diagnostics
  • Abbott Molecular Inc.
  • Foundation Medicine, Inc.
  • Roche Group
  • Ventana Medical Systems, Inc.

Phase IV ##. ##. ## CLINICAL TRIALS ANALYSIS FIGURE ##: EXPERT OPINIONS ##. ##. ## PHASE II CLINICAL TRAILS TABLE ##: PHASE II CLINICAL TRAILS US The Drug Rediscovery Protocol (DRUP Trial) (DRUP) A Randomized, ##x## Factorial Design Biomarker Prevention Trial of Lowdose Aspirin and Metformin in Stage I-

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

Other risk factors associated with Clostridium difficile infection include surgery of the gastrointestinal (GI) tract, diseases of the colon, such as inflammatory bowel disease or colorectal cancer, weakened immune system, use of chemotherapy drugs, previous Clostridium difficile i

  • Immunodiagnostics
  • Molecular Diagnostics
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Olympus Corporation

In addition to Sabalza, Malamud, and Montagna, study authors on the PLOS ONE article include Cheryl A.

  • HIV AIDS
  • Infectious Disease
  • Molecular Diagnostics
  • United States
  • Rheonix, Inc.